200 related articles for article (PubMed ID: 9816259)
21. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
Greene RF; Collins JM
Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of iododeoxyuridine into DNA of granulocytes in patients.
Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM
Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; Stetson PL; Maybaum J; Ensminger WD
Cancer Res; 1994 Jun; 54(11):2964-8. PubMed ID: 8187082
[TBL] [Abstract][Full Text] [Related]
25. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
Chi KH; Kunugi KA; Kinsella TJ
Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
[TBL] [Abstract][Full Text] [Related]
26. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
[TBL] [Abstract][Full Text] [Related]
27. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
[TBL] [Abstract][Full Text] [Related]
28. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
29. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
[TBL] [Abstract][Full Text] [Related]
31. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the activation of fluorodeoxyuridine by substrate competition and feedback inhibition in 647V cells.
Vazquez-Padua MA; Risueno C; Fischer PH
Cancer Res; 1989 Feb; 49(3):618-24. PubMed ID: 2521299
[TBL] [Abstract][Full Text] [Related]
33. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
Buchegger F; Adamer F; Schaffland AO; Kosinski M; Grannavel C; Dupertuis YM; de Tribolet N; Mach JP; Delaloye AB
Int J Cancer; 2004 May; 110(1):145-9. PubMed ID: 15054880
[TBL] [Abstract][Full Text] [Related]
34. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
Fischer PH; Murphy DG; Kawahara R
Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
[TBL] [Abstract][Full Text] [Related]
35. An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
Kinsella TJ; Kunugi KA; Vielhuber KA; McCulloch W; Liu SH; Cheng YC
Cancer Res; 1994 May; 54(10):2695-700. PubMed ID: 8168099
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
37. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
[TBL] [Abstract][Full Text] [Related]
38. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
39. Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts.
Kinsella TJ; Vielhuber KA; Kunugi KA; Schupp J; Davis TW; Sands H
Clin Cancer Res; 2000 Apr; 6(4):1468-75. PubMed ID: 10778979
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation.
Klecker RW; Jenkins JF; Kinsella TJ; Fine RL; Strong JM; Collins JM
Clin Pharmacol Ther; 1985 Jul; 38(1):45-51. PubMed ID: 4006375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
